Acute Ischemic Stroke AIS Clinical Trial
Official title:
PERFUSION AIS - Pulse Endovascular ReperFUSION for Acute Ischemic Stroke: An Early Feasibility Clinical Study
Prospective, multi-center, single-arm early feasibility study enrolling a minimum of 15 subjects at up to a minimum of 3 active investigational sites in the United States. The subjects must be diagnosed with acute ischemic stroke (AIS), must be post-mechanical thrombectomy, will have had intravenous thrombolytics, and have a visible MCA, ACA or PCA occlusive clot on initial angiographic imaging. Each subject will receive the Pulse NanoMED procedure after attempted neurovascular therapy to achieve better reperfusion.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02455440 -
Esmolol Infusion in Patients Undergoing Craniotomy
|
Phase 3 | |
| Completed |
NCT00512447 -
Normal Values of Brain Oxygenation
|
N/A |